CMS is set to lower costs for Wegovy and Zepbound weight loss drugs, potentially improving coverage and access for Medicare, Medicaid, and commercial insurance patients amid varied state and employer restrictions.

MorningStar Laboratories launches SmartVascular Dx test in Western US with expanded payer coverage including BCBS Arizona and Medicare, enhancing vascular disease detection and reimbursement access.